Quick Answer
Jin Medical International Ltd. reported Total Revenue of $20.69 million for fiscal year 2025.
Jin Medical International Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $20.69M -12.0% |
$23.50M +18.6% |
$19.82M +3.3% |
$19.19M -7.6% |
$20.76M | — |
| Net Income | $1.19M -67.6% |
$3.68M +27.7% |
$2.88M +6.3% |
$2.71M +2.8% |
$2.63M | — |
| Diluted EPS | $0.01 -50.0% |
$0.02 +0.0% |
$0.02 +0.0% |
$0.02 +0.0% |
$0.02 | — |
| Total Assets | $53.37M +16.5% |
$45.80M +39.2% |
$32.90M +57.1% |
$20.94M | — | — |
| Stockholders Equity | $29.64M +2.9% |
$28.82M +20.2% |
$23.98M +57.4% |
$15.24M +8.6% |
$14.03M +29.9% |
$10.80M |
| R&D Expense | $1.56M +4.0% |
$1.50M -3.0% |
$1.54M -18.5% |
$1.89M +20.8% |
$1.57M | — |
| Operating Income | $608.2K -83.3% |
$3.64M +26.9% |
$2.87M +34.6% |
$2.13M -19.0% |
$2.63M | — |
| Gross Profit | $6.04M -36.4% |
$9.50M +40.1% |
$6.78M +9.5% |
$6.20M -2.6% |
$6.36M | — |
| Shares Outstanding | 156.55M +0.4% |
155.95M +0.0% |
155.95M +15.5% |
135.00M | — | — |
- Jin Medical International Ltd. reported Total Revenue of $20.69 million for fiscal year 2025.
- Jin Medical International Ltd. showed a decrease of -12.0% in Total Revenue compared to the prior fiscal year.
- Jin Medical International Ltd. reported Net Income of $1.19 million for fiscal year 2025.
- Jin Medical International Ltd. showed a decrease of -67.6% in Net Income compared to the prior fiscal year.
- Jin Medical International Ltd. reported Diluted EPS of $0.01 per share for fiscal year 2025.
- Jin Medical International Ltd. showed a decrease of -50.0% in Diluted EPS compared to the prior fiscal year.
- Jin Medical International Ltd. reported Total Assets of $53.37 million for fiscal year 2025.
- Jin Medical International Ltd. showed an increase of +16.5% in Total Assets compared to the prior fiscal year.
- Jin Medical International Ltd. reported Stockholders Equity of $29.64 million for fiscal year 2025.
- Jin Medical International Ltd. showed an increase of +2.9% in Stockholders Equity compared to the prior fiscal year.
- Jin Medical International Ltd. reported R&D Expense of $1.56 million for fiscal year 2025.
- Jin Medical International Ltd. showed an increase of +4.0% in R&D Expense compared to the prior fiscal year.
- Jin Medical International Ltd. reported Operating Income of $608.2 thousand for fiscal year 2025.
- Jin Medical International Ltd. showed a decrease of -83.3% in Operating Income compared to the prior fiscal year.
- Jin Medical International Ltd. reported Gross Profit of $6.04 million for fiscal year 2025.
- Jin Medical International Ltd. showed a decrease of -36.4% in Gross Profit compared to the prior fiscal year.
- Jin Medical International Ltd. reported Shares Outstanding of 156.55 million shares for fiscal year 2025.
- Jin Medical International Ltd. showed an increase of +0.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: